Cargando…
Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
SIMPLE SUMMARY: Triple-negative breast cancer (TNBC), the most aggressive and heterogenous type of cancer, lacks the expression of hormones like estrogen, progesterone, and human epidermal growth receptor-2, making chemotherapy the only treatment regimen against TNBC. It was further observed that ch...
Autores principales: | Chaudhuri, Aiswarya, Kumar, Dulla Naveen, Dehari, Deepa, Patil, Rohit, Singh, Sanjay, Kumar, Dinesh, Agrawal, Ashish Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177107/ https://www.ncbi.nlm.nih.gov/pubmed/37174125 http://dx.doi.org/10.3390/cancers15092661 |
Ejemplares similares
-
Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
por: Chaudhuri, Aiswarya, et al.
Publicado: (2022) -
A Bacteriophage Microgel Effectively Treats the Multidrug-Resistant Acinetobacter baumannii Bacterial Infections in Burn Wounds
por: Dehari, Deepa, et al.
Publicado: (2023) -
Combination Therapy Comprising Paclitaxel and 5-Fluorouracil by Using Folic Acid Functionalized Bovine Milk Exosomes Improves the Therapeutic Efficacy against Breast Cancer
por: Kumar, Dulla Naveen, et al.
Publicado: (2022) -
Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application
por: Kumar, Dulla Naveen, et al.
Publicado: (2022) -
Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy
por: Chaudhuri, Aiswarya, et al.
Publicado: (2022)